152 related articles for article (PubMed ID: 21809032)
21. Pertussis toxin utilizes proximal components of the T-cell receptor complex to initiate signal transduction events in T cells.
Schneider OD; Weiss AA; Miller WE
Infect Immun; 2007 Aug; 75(8):4040-9. PubMed ID: 17562776
[TBL] [Abstract][Full Text] [Related]
22. A potential role for protein tyrosine kinase p56(lck) in rheumatoid arthritis synovial fluid T lymphocyte hyporesponsiveness.
Romagnoli P; Strahan D; Pelosi M; Cantagrel A; van Meerwijk JP
Int Immunol; 2001 Mar; 13(3):305-12. PubMed ID: 11222499
[TBL] [Abstract][Full Text] [Related]
23. Differential Src family kinase activity requirements for CD3 zeta phosphorylation/ZAP70 recruitment and CD3 epsilon phosphorylation.
Lysechko TL; Ostergaard HL
J Immunol; 2005 Jun; 174(12):7807-14. PubMed ID: 15944285
[TBL] [Abstract][Full Text] [Related]
24. Contribution of p56lck to the upregulation of cytokine production and T cell proliferation by IL-2 in human CD3-stimulated T cell clones.
Eljaafari A; Dorval I; Soula M; Quelvennec E; Pirenne H; Fagard R; Sterkers G
Cell Immunol; 1995 Jan; 160(1):152-6. PubMed ID: 7842481
[TBL] [Abstract][Full Text] [Related]
25. Reduced T-cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection.
Seitzer U; Kayser K; Höhn H; Entzian P; Wacker HH; Ploetz S; Flad HD; Gerdes J; Maeurer MJ
Immunology; 2001 Nov; 104(3):269-77. PubMed ID: 11722641
[TBL] [Abstract][Full Text] [Related]
26. PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitor.
Fujimura A; Nakayama K; Imaizumi A; Kawamoto M; Oyama Y; Ichimiya S; Umebayashi M; Koya N; Morisaki T; Nakagawa T; Onishi H
Cancer Immunol Immunother; 2019 Oct; 68(10):1649-1660. PubMed ID: 31562536
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-2 mediated regulation of mitogen-activated T cell reactivity from different lymphoid sources in patients with squamous cell carcinoma of the oral cavity.
Murali PS; Somasundaram R; Rao RS; Fakih AR; Gangal SG
J Oral Pathol Med; 1989 Jul; 18(6):327-32. PubMed ID: 2810131
[TBL] [Abstract][Full Text] [Related]
28. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signaling by targeting ZAP-70.
Chen Z; Chen L; Qiao SW; Nagaishi T; Blumberg RS
J Immunol; 2008 May; 180(9):6085-93. PubMed ID: 18424730
[TBL] [Abstract][Full Text] [Related]
29. TCR subunit specificity of CTLA-4-mediated signaling.
Siu E; Carreno BM; Madrenas J
J Leukoc Biol; 2003 Dec; 74(6):1102-7. PubMed ID: 12972512
[TBL] [Abstract][Full Text] [Related]
30. Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2.
Salvadori S; Zier K
J Immunol; 1996 Apr; 156(8):2927-32. PubMed ID: 8609413
[TBL] [Abstract][Full Text] [Related]
31. T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity.
Levey DL; Srivastava PK
J Exp Med; 1995 Oct; 182(4):1029-36. PubMed ID: 7561676
[TBL] [Abstract][Full Text] [Related]
32. Transfer of the interleukin-2 gene into human cancer cells induces specific antitumor recognition and restores the expression of CD3/T-cell receptor associated signal transduction molecules.
Guarini A; Riera L; Cignetti A; Montacchini L; Massaia M; Foa R
Blood; 1997 Jan; 89(1):212-8. PubMed ID: 8978294
[TBL] [Abstract][Full Text] [Related]
33. Mutation of tyrosines 492/493 in the kinase domain of ZAP-70 affects multiple T-cell receptor signaling pathways.
Mège D; Di Bartolo V; Germain V; Tuosto L; Michel F; Acuto O
J Biol Chem; 1996 Dec; 271(51):32644-52. PubMed ID: 8955094
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of the T-cell antigen receptor-CD3 complex signaling pathway by the tyrosine phosphatase inhibitor pervanadate is mediated by inhibition of CD45: evidence for two interconnected Lck/Fyn- or zap-70-dependent signaling pathways.
Imbert V; Farahifar D; Auberger P; Mary D; Rossi B; Peyron JF
J Inflamm; 1996; 46(2):65-77. PubMed ID: 8734787
[TBL] [Abstract][Full Text] [Related]
35. Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner.
Seggewiss R; Loré K; Greiner E; Magnusson MK; Price DA; Douek DC; Dunbar CE; Wiestner A
Blood; 2005 Mar; 105(6):2473-9. PubMed ID: 15572591
[TBL] [Abstract][Full Text] [Related]
36. Cloning, characterization, and expression pattern of Atlantic halibut (Hippoglossus hippoglossus L.) CD4-2, Lck, and ZAP-70.
Øvergård AC; Nerland AH; Patel S
Fish Shellfish Immunol; 2010 Dec; 29(6):987-97. PubMed ID: 20728542
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling.
Smeets RL; Fleuren WW; He X; Vink PM; Wijnands F; Gorecka M; Klop H; Bauerschmidt S; Garritsen A; Koenen HJ; Joosten I; Boots AM; Alkema W
BMC Immunol; 2012 Mar; 13():12. PubMed ID: 22413885
[TBL] [Abstract][Full Text] [Related]
38. Insufficient deactivation of the protein tyrosine kinase lck amplifies T-cell responsiveness in acute coronary syndrome.
Pryshchep S; Goronzy JJ; Parashar S; Weyand CM
Circ Res; 2010 Mar; 106(4):769-78. PubMed ID: 20035083
[TBL] [Abstract][Full Text] [Related]
39. T cell-specific adapter protein inhibits T cell activation by modulating Lck activity.
Sundvold V; Torgersen KM; Post NH; Marti F; King PD; Røttingen JA; Spurkland A; Lea T
J Immunol; 2000 Sep; 165(6):2927-31. PubMed ID: 10975797
[TBL] [Abstract][Full Text] [Related]
40. Deficient expression of p56(lck) in Th2 cells leads to partial TCR signaling and a dysregulation in lymphokine mRNA levels.
al-Ramadi BK; Nakamura T; Leitenberg D; Bothwell AL
J Immunol; 1996 Dec; 157(11):4751-61. PubMed ID: 8943376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
